AHCO analyst estimates
AdaptHealth (AHCO) analyst ratings, the average price target and its range, and every firm's latest call.
AHCO analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 17, 2026 | Robert W. Baird | AdaptHealth price target lowered to $9 from $10 at Baird | $9.00 |
| Aug 6, 2026 | RBC Capital | AdaptHealth price target lowered to $8 from $15 at RBC Capital | $8.00 |
| Aug 6, 2026 | UBS | AdaptHealth price target lowered to $10 from $14 at UBS | $10.00 |
| Aug 5, 2026 | Canaccord Genuity | AdaptHealth price target lowered to $10 from $16 at Canaccord | $10.00 |
| Aug 5, 2026 | Robert W. Baird | AdaptHealth price target lowered to $10 from $15 at Baird | $10.00 |
| Aug 5, 2026 | Truist Financial | AdaptHealth price target lowered to $9 from $14 at Truist | $9.00 |
| Jul 21, 2026 | Jefferies | Jefferies Upgrades AdaptHealth (AHCO) to Buy | $13.00 |
| Jul 6, 2026 | Robert W. Baird | AdaptHealth price target lowered to $15 from $18 at Baird | $15.00 |
| May 11, 2026 | RBC Capital | AdaptHealth price target raised to $15 from $13 at RBC Capital | $15.00 |
| May 6, 2026 | Robert W. Baird | AdaptHealth price target raised to $18 from $17 at Baird | $18.00 |
| May 6, 2026 | Canaccord Genuity | AdaptHealth price target raised to $16 from $14 at Canaccord | $16.00 |
| Apr 20, 2026 | Jefferies | AdaptHealth price target raised to $11 from $9.50 at Jefferies | $11.00 |
| Feb 26, 2026 | Leerink Partners | AdaptHealth (AHCO) PT Lowered to $12 at Leerink Partners | $12.00 |
| Feb 25, 2026 | RBC Capital | RBC Capital on AdaptHealth (AHCO): 'Shares Appear Oversold Following Solid Guidance' | $13.00 |
| Nov 15, 2024 | Truist Financial | AdaptHealth (AHCO) PT Lowered to $12 at Truist Securities | $12.00 |
- 7 firms rate AHCO: 7 buy, 0 hold, 0 sell.
- The average price target is $9.83 from 6 analysts, from $8.00 to $13.00.
Updated 2026-11-03 00:02 UTC